Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)

NCT00883129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma
Interstitial Lung Disease

Interventions

DRUG: Mycophenolate mofetil
DRUG: Cyclophosphamide
DRUG: Placebo

Sponsor

Michael Roth

Collaborators

[object Object]
[object Object]